pharmaphorum

JANUARY 19, 2021

A survey by rare disease patient network Raremark found that 86% of the community members asked were interested in taking part in clinical trials. CEO Jeremy Edwards looks at how decentralised trial models can solve some of the challenges for clinical trial recruitment in rare disease. With low and geographically dispersed patient populations in rare disease, deciding where best to place trial sites can be a headache for sponsors.

Adverse Reactions 133

Adverse Reactions Communication Hospitals Compounding 133

Outsourcing Pharma

JANUARY 18, 2021

A representative from the global CRO outlines how forces like COVID-19, decentralized studies, globalization and others are driving change in the industry.

105

105

Druggist

JANUARY 21, 2021

The main focus of today’s post is to review the most popular prescription painkillers in the UK. I previously reviewed the popularity of different drugs in the UK, which may interest you: Top 15 most prescribed drugs in the UK & most popular antidepressants in the UK. Most popular prescription painkillers (UK) will be ranked according to the volume of prescriptions issued in the last 12 months by GPs in the UK.

Compounding 92

Compounding 92

Pharma Times

JANUARY 21, 2021

Over 400,000 people in the UK live with RA

55

55

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

JANUARY 20, 2021

Ella Balasa says she owes her life to the experimental phage therapy she was able access in no small part thanks to her scientific background. Her mission, she told pharmaphorum, is to ensure everyone has the knowledge and power they need to navigate their own healthcare journey, no matter where they are from or what they do. Ella, 28, was diagnosed with cystic fibrosis – a rare genetic disease which causes a build-up of thick, sticky mucus in the lungs, digestive tract, and sinuses – at 18 mont

Hospitals 113

Hospitals FDA 113

Outsourcing Pharma

JANUARY 18, 2021

A leader from Oracle Health Sciences examines the dynamic, challenging year and highlights creativity and ingenuity displayed by research professionals.

105

105

Pharma Times

JANUARY 18, 2021

Therapy approved for the treatment of paediatric patients with anaplastic large cell lymphoma

FDA 55

FDA 55

pharmaphorum

JANUARY 21, 2021

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia. This is the first project to be funded by the international Psychiatry Consortium, a £4 million collaboration between seven global pharmaceutical companies, and two leading research charities, convened and managed by the Medicines Discovery Catapult, that supports high

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies 111

Outsourcing Pharma

JANUARY 21, 2021

The trials, funded by the American Heart Association, will harness the companyâs Verisense wearable sensor platform to examine brain-heart health links.

86

86

The deprescribing.org Blog

JANUARY 20, 2021

Hello, deprescribers! Today we are excited to have another interview post with clinical pharmacist Pam Howell (Ontario, Canada), telling us about her (deprescribing) experiences working as part of the telemedicine initiative GeriMedRisk. Q: You are part of the GeriMedRisk initiative. First off, can you tell us a little bit about GeriMedRisk and how the consultation service works?

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

JANUARY 18, 2021

Partnership aims to transform HIV patient care with digital services

Hospitals 52

Hospitals Patient Care 52

pharmaphorum

JANUARY 19, 2021

A new survey highlights the importance of customer reference data to digital transformation and analyses ways pharma companies can improve the quality of their datasets. In a remote world, customer data is more foundational than ever, and Veeva’s 2020 European Customer Reference Data Survey found 91% of organisations view customer data as a global strategic asset, while 88% said it’s essential for new product launches or sales models.

103

103

Outsourcing Pharma

JANUARY 19, 2021

The pharma giant has invested in the clinical trial exploring the viability of Vedanta Biosciencesâ VE202 inflammatory bowel disease treatment candidate.

69

69

indispensable health

JANUARY 19, 2021

Many pharmacy professionals are needing to juggle increasing job responsibilities with decreasing time to complete tasks. Pharmacy leaders must know not only are they not immune to this, the pharmacy staff they manage isn’t either. As a result everyone on the pharmacy team can often be pulled in many directions. An unfortunate final piece to this introductory framework is the current COVID-19 pandemic.

Immunization 52

Immunization 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Times

JANUARY 20, 2021

PIM status was awarded on the basis of Phase IIb results of nirsevimab

52

52

pharmaphorum

JANUARY 22, 2021

NICE has said that the NHS should not fund Bristol-Myers Squibb’s multiple sclerosis pill Zeposia (ozanimod) for relapsing multiple sclerosis in first draft guidance. The cost-effectiveness body said that trial evidence showed Zeposia cuts the number of relapses and brain lesions compared with Biogen’s Avonex (interferon beta-1a). But in its first draft guidance NICE said that Zeposia’s effect on progression of disability is unclear.

98

98

Outsourcing Pharma

JANUARY 21, 2021

A leader from the supply-chain specialist explains vulnerabilities and challenges unique to pharma, and how professionals can safeguard and streamline.

52

52

Pharma Mirror

JANUARY 19, 2021

The chances are that at some point in the last year when you’ve been talking to someone about how hard it’s been to keep track of and to keep on top of your workload when more and more people are working from home, and everything is so up in the air, that someone will have recommended a management software that they swear by. They will have told you that it has made their work-life immeasurably easier and that they cannot remember how they ever got by without it.

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Times

JANUARY 22, 2021

Cabenuva consists of ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine

51

51

pharmaphorum

JANUARY 20, 2021

Laboratory studies have confirmed that antibodies stimulated by Pfizer and BioNTech’s COVID-19 vaccine can neutralise the new, more transmissible variant of SARS-CoV-2 identified in the UK. The results of the study – published online prior to peer review – are among the first data to indicate that any of the approved coronavirus vaccines can effectively target the mutated spike protein in the UK strain, known as B.1.1.7 lineage or VOC 202012/01.

Vaccines 98

Vaccines Communication Immunization 98

Outsourcing Pharma

JANUARY 21, 2021

The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines, including a COVID-19 treatment.

52

52

Pharma Mirror

JANUARY 19, 2021

The chances are that at some point in the last year when you’ve been talking to someone about how hard it’s been to keep track of and to keep on top of your workload when more and more people are working from home, and everything is so up in the air, that someone will have recommended a management software that they swear by. They will have told you that it has made their work-life immeasurably easier and that they cannot remember how they ever got by without it.

52

52

Pharma Times

JANUARY 22, 2021

Cost-effectiveness estimates 'uncertain', according to NICE

49

49

pharmaphorum

JANUARY 18, 2021

Johnson & Johnson’s Darzalex Faspro has become the first product approved by the FDA to treat light chain (AL) amyloidosis, a rare and often fatal blood cell disorder. The new indication is the second for Darzalex Faspro, a subcutaneous version of blockbuster intravenous therapy Darzalex (daratumumab) which is used to treat multiple myeloma on its own and as part of multiple combination therapies.

Chemotherapy 98

Chemotherapy FDA 98

Outsourcing Pharma

JANUARY 19, 2021

Formerly Parexel Informatics, the renamed clinical research technology company has broken off and will operate as an independent company going forward.

52

52

Med Ed 101

JANUARY 20, 2021

Many have asked me what are the pros and cons of doing BCPS recertification by exam. Here are my thoughts on this. BCPS Recertification by Exam: The Pros If you are anything like me, I learn best when I have something I am preparing for. One of the great advantages of preparing to retake the […]. The post BCPS Recertification By Exam Pros and Cons appeared first on Med Ed 101.

40

40

Pharma Times

JANUARY 22, 2021

Company has completed genetic analysis for UK and South African variants

49

49

pharmaphorum

JANUARY 19, 2021

The Scottish Medicines Consortium (SMC) has given a green light to Roche’s Rozlytrek for a rare form of lung cancer, almost seven months after NICE backed the drug in England. Rozlytrek (entrectinib) can now be used by the NHS in Scotland as a treatment option for ROS1-positive, advanced non-small cell lung cancer (NSCLC) not previously treated with ROS1 inhibitors.

Chemotherapy 98

Chemotherapy Immunization 98

Outsourcing Pharma

JANUARY 18, 2021

California information technology and services company Syntegra and the National Institutes of Health (NIH) have signed a partnership to 'democratize access to the largest set of COVID-19 patient records': with the use of Syntegra's synthetic data engine.

52

52

Med Ed 101

JANUARY 17, 2021

Tramadol is used in clinical practice, but it does have numerous drug interactions that you should be aware of. When reviewing a medication list or when a patient starts a new medication, here are some of the items that I think about when monitoring for tramadol drug interactions. Seizure Risk Antiepileptic agents are always something […]. The post Tramadol Drug Interactions appeared first on Med Ed 101.

40

40

Pharma Times

JANUARY 21, 2021

Antibodies in blood of vaccinated individuals neutralised in vivo version of variant

Vaccines 49

Vaccines 49

pharmaphorum

JANUARY 21, 2021

With clinical holds lifting there has been more investment and clinical progress in the gene therapy for muscular disorders space than ever before, yet the consequences of toxicity are not a distant memory. Despite the successes, there are still withstanding challenges for gene therapy developers targeting the muscle when it comes to optimizing delivery and navigating toxicity to develop truly safe and transformative therapeutics for muscular disorders patients.

96

96

Board Vitals - Pharmacist

JANUARY 18, 2021

The ABIM Cardiology Board Exam is a difficult test, but the content is very learnable. The average pass rate is ~93% over the past several years, which happens to be higher than most of the other Medical Specialty Boards. On the other hand, Cardiologists may simply be more prepared, and that’s the reason for the higher pass rate. Test your knowledge with some of our sample Cardiology Board Review Practice Questions!

52

52